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Abstract 
 
Background: In 2015, World Health Organization (WHO) discovered 10.4 million tuberculosis (TB) cases around the 
world. Multidrug-resistant tuberculosis (MDR-TB) became a threat because it has high mortality number. There were 
480,000 new MDR-TB cases in 2015. Based on those problems, diagnostic development to detect M. tuberculosis 
rapidly and accurately is needed. The importance of detecting epitope expression of esxA full gene because there was a 
potential of complexity over the protein structure and might affect the protein concentration. By knowing epitope 
prediction, there’s an expectation that it can help the development of TB diagnostic. This research was aimed to 
determine the T cell epitope prediction of esxA full gene from MDR-TB patients 
Material and Methods: Total of 24 MDR-TB sputum isolate from TB patients at Dr. Soetomo Hospital were collected 
from September to December 2016. Samples were confirmed as MDR-TB using GeneXpert and Bactec MGIT 960. 
Those samples tested using PCR targeted 580 bp of esxA gene and sequencing. Gene sequence was aligned against wild 
type using Bioedit program version 7.2.5 and NCBI BLAST. T cell epitope prediction was analyzed by GENETYX 
version 10. 
Results: Epitope predictions that could be obtained were IEAAAS, ASAIQG, VTSIHS, TKLAAA, VTGMFA based 
IAd Pattern Position and EAAAS based Rothbard/Taylor Pattern Position. Those prediction epitopes can determine the 
severity of disease, therefore full gene of esxA could be used as diagnostic target.  
Conclusion: This research discovered five specific T cell epitope prediction based on IAd Pattern Position and one 
epitope prediction according to Rothbard/Taylor Pattern Position. 
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Introduction 
 
Tuberculosis (TB) is one of deadly infectious diseases transmitted by air. WHO reported that there were 
10.4 million TB cases with 1.4 million deaths in 2015. Not only that, there were an additional 0.4 million deaths 
because of TB in HIV patients (WHO, 2016). In addition, there were 480,000 new cases of multidrug-resistant 
tuberculosis (MDR-TB) with 1,000 people infected by rifampicin-resistant (RR-TB) needed second line antibiotic 
(WHO, 2016).  
Indonesia was one of the countries with high burden of TB and ranked as second highest TB burden country in the 
world for two years consecutively, in 2014 and 2015. In 2015, new MDR/RR-TB cases in Indonesia was 2,8%. 
Incidence rate of all TB cases in Indonesia were about 395 cases per 100,000 populations in 2015. In addition, only 
52% of MDR-TB patients were successfully treated, mostly because of high number of mortality and patients with loss 
to follow up (WHO, 2015; WHO, 2016).  
Because of this problem, good management of TB patients and developing an accurate diagnostic to detect M. 
tuberculosis is needed. The esxA, a gene which encodes 6kDa early secretory antigenic target (ESAT-6), is one of the 
most important virulence factors of M. tuberculosis and has a potential to be the target of TB diagnostic.  
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The esxA is known as a conserved gene in M. tuberculosis and belong to region of difference 1 (RD-1). The RD-1 
region is removed to create BCG (Bacillus Calmette-Guerin) vaccine (Ganguly et al., 2008; Callahan et al., 2010). 
ESAT-6 is known to inhibit macrophage activation, induce apoptosis, and interfere with host immunity. ESAT-6 is also 
a membrane lytic factor that allows M. tuberculosis avoiding phagosomal attack because ESAT-6 was able to suppress 
autophagosome formation (Solans et al., 2014; Yu and Xie, 2012).  
However, MDR-TB cases are making diagnostic development of TB quite hard to do. Some studies stated that 
resistance of bacteria towards antibiotic was correlated to fitness cost of the bacteria (Melnyk et al., 2014; Cohen at al., 
2003; Salvatore et al., 2016). Previous study stated that resistance caused by mutation was associated with bacteria’s 
fitness cost because the mutation targeted gene encoded important cellular function (Cohen at al., 2003). There’s 
another study which also said that resistant M. tuberculosis was found to be less viable than antibiotic-sensitive M. 
tuberculosis both in vivo or in vitro. Several cases showed that resistant M. tuberculosis also had lower transmission 
rate (Kim et al., 2006; Comas et al., 2012). However, Cohen et al. (2003) reported that mutant with both lower and 
equal fitness cost value than antibiotic-sensitive M. tuberculosis had been found. 
Based on those studies, it is suspected that mutation on genes involved in anti-TB drugs such as rpoB, katG, and 
others can affect its secretion of virulence genes, causing different severity degrees to manifest on MDR-TB patients. 
Detection of epitope expression of full gene esxA as virulence gene was important to do because there was a potential 
of complexity over the epitope and could affect the protein structure along with the level of protein concentration which 
played an important role in the pathogenesis of TB. By knowing epitope prediction, there’s an expectation that it can 
help the development of TB diagnostic. The aim of this study was to determine the T cell epitope prediction of esxA 
full gene from MDR-TB patients.  
 
Materials and Methods   
 
Total of 24 MDR-TB sputum isolates samples from pulmonary TB patients in Dr. Soetomo Hospital, Surabaya, 
Indonesia were collected on September to December 2016. Samples were confirmed as MDR-TB using GeneXpert and 
Bactec MGIT 960 test (BD system) (Cepheid, 2015; Siddiqi and Rüsch-Gerdes, 2006; Hasan et al., 2013). Samples 
were then tested using the polymerase chain reaction (PCR) performed at the ITD Laboratory, Universitas Airlangga, 
Surabaya. The study was approved by ethics committee in health research of Dr. Soetomo Hospital with ethical 
clearance number 541/Panke.KKE/IX/2016 and has been approved at 27 September 2016.   
Sputum was decontaminated and concentrated using Alkali Petrof method recommended by WHO, process was 
first done before extraction and PCR process (WHO, 1998). DNA was extracted using QiAmp DNA Kit (DNeasy 
Blood & Easy Kit, Cat No. 69504) and followed with PCR process. Primer for PCR process was designed using Clone 
Manager software 6, version 6.00 targeted at 580 bp. KAPA2G Fast Ready-Mix PCR Kit was used as PCR Master 
Mix. The solution mixture consisted of 25 μl KAPA2G Fast Ready-Mix PCR Kit, 1 μl of 10 μM pair of primer, 20 μl 
nuclease-free water, and 3μl of DNA template. 
The amplification reaction in thermal cycle started with pre-denaturation at 95°C for 3 minutes, continued by 
denaturation at 95°C for 10 seconds, annealing at 58.3°C for 10 seconds, and extension at 72°C for 15 seconds. 
Denaturation, annealing and extension process was done for 35 cycles and finished with final extension at 72°C for 10 
minutes. Positive amplicon results were confirmed by the presence of DNA bands at 580 bp. 
Sequencing processes performed by sending PCR products to 1st BASE. 1st BASE used ABI PRISM 3730xl 
Genetic Analyzer developed by Applied Biosystem. Samples sequence was then analyzed using Bioedit program 
version 7.2.5 and NCBI BLAST to determine homology percentage between the sample and the wild-type M. 
tuberculosis H37Rv (NC_000962.3) sequence referenced from GenBank. T cell epitope prediction was analyzed by 
GENETYX version 10.  
 
Results 
 
In this study, total of 24 sputum samples from MDR-TB patients previously examined using PCR were found 
positive of full gene esxA (100%), as indicated by 580 bp DNA band. All samples then went into sequencing process in 
1st BASE, Singapore. The result of alignment in Bioedit version 7.2.5 showed that all samples sequenced had 100% 
homology to wild-type M. tuberculosis H37Rv (NC_000962.3) sequence. 
Samples sequence were also analyzed using the NCBI BLAST program, which result was that all examined 
samples had a 100% homology against M. tuberculosis H37Rv. Samples also had 100% homology percentage on 
Mycobacterium tuberculosis complex (MTBC) systems, such as Mycobacterium bovis, Mycobacterium caprae, and 
Mycobacterium africanum. Three other strains were discovered to have 99% homology with the sample, such as M. 
tuberculosis strain 96121, M. tuberculosis RGTB327, and one other organism from MTBC, namely M. canetti CIPT 
140060008 (Table 1).  
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Table 1. Homology of MDR-TB sputum sample isolate with bacteria in NCBI database 
No Bacteria species Query coverage 
(%) 
E value Identity 
(%) 
1. M. caprae (MTBC) 100 0,0 100 
2. M. bovis (MTBC) 100 0,0 100 
3. M. africanum 100 0,0 100 
4. M. tuberculosis H37Rv   100 0,0 100 
5. M. tuberculosis strain Beijing 100 0,0 100 
6. M. canetti (MTBC) 100 0,0 100 
7. M. tuberculosis H37Ra 100 0,0 100 
8. M. tuberculosis strain 96121 100 0,0 99 
9. M. canetti CIPT 140060008 (MTBC) 100 0,0 99 
10. M. tuberculosis RGTB327 100 0,0 99 
 
By using GENETYX ver. 10, epitope prediction of all the 24 samples were IEAAAS, ASAIQG, VTSIHS, 
TKLAAA, VTGMFA based on IAd Pattern Position and EAAAS based on Rothbard/Taylor Pattern Position. Those 
prediction epitopes can determine the severity of disease, therefore full gene of esxA could be used as diagnostic target 
(Table 2). 
 
Table 2. Prediction of T cell epitope esxA gene in sputum sample of MDR-TB patients 
Gene T cell epitope  
IAd Pattern Position Rothbard/Taylor Pattern Position 
Amino acid 
position Sequence  
Amino acid 
position Sequence  
esxA 
11-16 IEAAAS 12-16 EAAAS 
15-20 ASAIQG   
22-27 VTSIHS   
37-42 TKLAAA   
90-95 VTGMFA   
 
 
Discussion 
 
Several studies have suggested that mutations occurring in bacteria could interfere with their fitness cost. Previous 
research explained that resistant M. tuberculosis strain in clinical sample has different fitness cost from that of mutated 
strain in laboratory. There is no depression of the growth from resistant M. tuberculosis in clinical sample strain and 
still possessed the same transmission power as antibiotic-sensitive bacteria (Cohen et al., 2003; Melnyk et al., 2014).  
In addition, mutations in gene targeted by anti-TB drugs possibly affecting secretion of the virulence genes such 
as esxA gene. Thus, there is a possibility that esxA gene could also be mutated and affected the virulence power of 
MDR-TB. However, the result of this experiment showed the opposite. The sequence of esxA gene showed that all 
samples had 100% homology with M. tuberculosis H37Rv (NC_000962.3) along with MTBC group and there was no 
similarity found towards NTM (Nontuberculous mycobacteria).  
This indicated that esxA gene is a conserved gene even in the MDR-TB sample. Previous research analyzing 
ESAT-6, Ag85B, and Ag85C sequence was in agreement with this research. In another study, mutation was also not 
found in esxA gene observed from 38 patients with MDR-TB (Mertaniasih et al., 2016; Uplekar et al., 2011). Another 
study also reported that there is no variation found in esxA gene from 88 clinical isolates (Davilla et al., 2010). Many 
previous studies stated that esx group from ESX-1 to ESX-4 gene cluster had fewer variation (Uplekar et al., 2011; 
Solans et al., 2014). 
Besides the similarity of esxA gene sequence with the wild type M. tuberculosis H37Rv, the result also showed 
that there is similarity to the functional structure of the epitope protein which is the determinant of immunodominant 
among the samples. Studying the function of the M. tuberculosis epitope could be a step to acknowledge the 
immunopathogenesis of TB, diagnostic development and vaccine development (Ivanyi, 2014). 
Understanding the epitope prediction of esxA gene is important to comprehend the immune response of human 
towards M. tuberculosis. A study stated that cellular immunity mediated by CD8+ T cells is important to control the 
latent M. tuberculosis infection (Zhai et al., 2016). In this study there were 5 epitope T cells analyzed by IAd Pattern 
Position and 1 epitope with Rothbard / Taylor Pattern Position. This result showed that the protein could be recognized 
by T cell lymphocytes and has high possibility to be used as vaccine candidate.   
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However, the results of the epitopes in this study showed different result with those reported by Mertaniasih et al. 
(2016) which acquired the epitope T cell prediction by IAd Pattern Position for only four epitopes. This is possible 
because the target gene captured in this study is much longer than that done by previous studies that only got 351 bp.  
One of the T cells epitope predictions in this research used Rothbard/Taylor Pattern which was calculated by the 
possible pattern of 4 (charged or glycine, hydrophobic, hydrophobic, polar or glycine) and 5 amino acids (charged or 
glycine, hydrophobic, hydrophobic, hydrophobic or proline, polar or glycine) that occurred in 15 random amino acid 
peptides. That pattern can be used to predict areas within protein that can be recognized by MHC class I and II 
accurately (Rothbard and Taylor, 1988).  
This study showed that the T-cell epitope predictions discovery was different from previous studies. This is a 
recent study of esxA gene exploration in patients with pulmonary tuberculosis in Indonesia. Those prediction epitopes 
can determine the severity of disease, therefore full gene of esxA could be used as diagnostic target. This research 
discovered five specifics T cell epitope prediction based on IAd Pattern Position and one epitope prediction according 
to Rothbard/Taylor Pattern Position. 
T cell’s response targeted a conserved epitope and it could be a benefit for the pathogen. Nayak et al. (2015) 
discovered several novel MTB proteins recognized by human T cells which could be a candidate for TB vaccine. 
ESAT-6 known as potent virulence factor in M. tuberculosis has a high potential as vaccine and diagnostic target for 
TB, thus knowing epitope prediction from esxA gene from various places especially countries with high incidence of 
TB is important.  
 
Conclusion 
 
This research proved that there were no variation or mutation found from nucleotide sequence among the MDR-
TB isolates of sputum. In addition, we discovered five specifics T cell epitopes prediction based on IAd Pattern 
Position and one epitope prediction according to Rothbard/Taylor Pattern Position which was different from previous 
study. 
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